
ACB.TO) is getting in the octagon with the UFC in an “exclusive, multi-year, multi-million dollar, global partnership” to advance CBD research." data-reactid="22">Aurora Cannabis Inc. is getting in the octagon with the UFC in an “exclusive, multi-year, multi-million dollar, global partnership” to advance CBD research.
The Edmonton-based cannabis producer said it will work with the fight league’s athletes in clinical studies involving pain management, inflammation, injury, exercise recovery, and mental well-being.
“This global partnership places focus squarely on the health and well-being of UFC's talented and highly trained athletes,” Aurora CEO Terry Booth wrote in a news release on Tuesday.
Aurora's research will be led by Dr. Jason Dyck, a professor at the University of Alberta and a Canada Research Chair in molecular medicine. He also serves as an independent director on Aurora’s board.
The research will be conducted at the UFC's Performance Institute in Las Vegas.